Web Images Videos Maps News Shopping Gmail more »
Sign in
Scholar Home  
  Advanced Scholar Search
Scholar Preferences
Scholar Results 1 - 10 of about 101 related to Rosenstock: Effects of the dipeptidyl peptidase-IV inhibitor vildagliptin on incretin hormones,.... (0.10 sec) 

Effects of the dipeptidyl peptidase-IV inhibitor vildagliptin on incretin hormones, …


J Rosenstock, JE Foley, M Rendell, M Landin- … - Diabetes Care, 2008 - Am Diabetes Assoc
RESEARCH DESIGN AND METHODS—A 12-week, double-blind, randomized, parallel-group
study comparing vildagliptin (50 mg qd) and placebo was conducted in 179 subjects with IGT
(2-h glucose 9.1 mmol/l, A1C 5.9%). Plasma levels of intact glucagon-like peptide 1 ...
Cited by 28 - Related articles - BL Direct - All 5 versions

Evidence that vildagliptin attenuates deterioration of glycaemic control during 2- …


WA Scherbaum, A Schweizer, A Mari, PM … - Diabetes Obes …, 2008 - interscience.wiley.com
It is also possible that your web browser is not configured or not able to display style sheets.
In this case, although the visual presentation will be degraded, the site should continue to be
functional. We recommend using the latest version of Microsoft or Mozilla web browser to ...
Cited by 19 - Related articles - All 3 versions

Efficacy and tolerability of vildagliptin vs. pioglitazone when added to metformin: a …


G Bolli, F Dotta, E Rochotte, SE Cohen - Diabetes Obes Metab, 2008 - interscience.wiley.com
It is also possible that your web browser is not configured or not able to display style sheets.
In this case, although the visual presentation will be degraded, the site should continue to be
functional. We recommend using the latest version of Microsoft or Mozilla web browser to ...
Cited by 49 - Related articles - All 2 versions

Measurements of islet function and glucose metabolism with the dipeptidyl …

- endojournals.org
K Azuma, Z Radikova, J Mancino, FGS Toledo, … - Journal of Clinical …, 2008 - Endocrine Soc
Objective: Pharmacological inhibition with the dipeptidyl peptidase 4 (DPP-4) inhibitor vildagliptin
prolongs the action of endogenously secreted incretin hormones leading to improved glycemic
control in patients with type 2 diabetes mellitus (T2DM). We undertook a double-blinded, ...
Cited by 24 - Related articles - BL Direct - All 4 versions

Efficacy and tolerability of vildagliptin in drug-naive patients with type 2 diabetes …


WA Scherbaum, A Schweizer, A Mari, PM … - Diabetes Obes …, 2008 - interscience.wiley.com
It is also possible that your web browser is not configured or not able to display style sheets.
In this case, although the visual presentation will be degraded, the site should continue to be
functional. We recommend using the latest version of Microsoft or Mozilla web browser to ...
Cited by 24 - Related articles - All 2 versions

Effects of vildagliptin on glucose control in patients with type 2 diabetes …


AJ Garber, JE Foley, MA Banerji, P Ebeling, … - Diabetes Obes …, 2008 - interscience.wiley.com
It is also possible that your web browser is not configured or not able to display style sheets.
In this case, although the visual presentation will be degraded, the site should continue to be
functional. We recommend using the latest version of Microsoft or Mozilla web browser to ...
Cited by 37 - Related articles - All 4 versions

Effects of the DPP-4 inhibitor vildagliptin on incretin hormones, islet function, and …

- diabetesjournals.org [PDF] 
J Rosenstock, JE Foley, M Rendell, M Landin- … - Diabetes Care, 2007 - Am Diabetes Assoc
Page 1. Effects of the DPP-4 Inhibitor Vildagliptin on Incretin Hormones, Islet Function, and
Postprandial Glycemia in Subjects with Impaired Glucose Tolerance Julio Rosenstock, MD
1 ; James E. Foley, PhD 2 ; Marc Rendell, MD 3 ; Mona Landin- ...
Cited by 4 - Related articles - All 3 versions

Effects of the DPP-4 Inhibitor Vildagliptin on Incretin Hormones, Islet Function, and …


S Basel, MA Baron - Am Diabetes Assoc
Julio Rosenstock, MD1; James E. Foley, PhD2; Marc Rendell, MD3; Mona Landin- Olsson,
MD, PhD4; Jens J. Holst, MD5; Carolyn F. Deacon, PhD5; Erika Rochotte, MSc6; Michelle A.
Baron, MD2 ... 1Dallas Diabetes and Endocrine Center, Dallas, Texas; 2Novartis ...
Related articles

Improved meal-related insulin processing contributes to the enhancement of B-cell …


B Ahren, G Pacini, A Tura, JE Foley, A … - Hormone and metabolic …, 2007 - ncbi.nlm.nih.gov
The aim of this study was to evaluate the contribution of insulin processing to the improved
meal-related B-cell function previously shown with the DPP-4 inhibitor vildagliptin. Fifty-five patients
with type 2 diabetes (56.5+/-1.5 years; BMI=29.6+/-0.5 kg/m(2); FPG=9.9+/-0.2 mmol/l; ...
Cited by 15 - Related articles - BL Direct - All 3 versions

The dipeptidyl peptidase IV inhibitor vildagliptin suppresses endogenous glucose …

- endojournals.org
B Balas, MR Baig, C Watson, BE Dunning, M … - Journal of Clinical …, 2007 - Endocrine Soc
Results: After vildagliptin, suppression of endogenous glucose production (EGP) during 6-h MTT
was greater than with placebo (1.02 ± 0.06 vs. 0.74 ± 0.06 mg·kg –1 ·min –1 ; P = 0.004), and
insulin secretion rate increased by 21% (P = 0.003) despite significant reduction in mean ...
Cited by 67 - Related articles - BL Direct - All 5 versions


Result Page: 

1

2

3

4

5

6

7

8

9

10

Next


 


Go to Google Home - About Google - About Google Scholar

©2009 Google